PMA device
Dimension FPSA Flex Reagent Cartridge
Siemens Healthcare Diagnostics · Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions (MTG, Class III) · First FDA decision Jan 24, 2003, newest Apr 13, 2018Prostate cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Dimension FPSA Flex"
MAUDE reports
0
Brand "Dimension FPSA Flex", since 2015
PubMed studies
0
Mentioning "Dimension FPSA Flex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dimension FPSA Flex Reagent Cartridge
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Dimension FPSA Flex Reagent CartridgePMA supplement
P020027-S028 · Decided Apr 13, 2018 · 200 days after receipt · Normal 180 Day Track No User Fee
Device type: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions (MTG) · Laboratory Medicine & Pathology
- DIMENSION FPSA FLEX REAGENT CARTRIDGEPMA supplement
P020027-S010 · Decided May 27, 2010 · 366 days after receipt · Normal 180 Day Track
Device type: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions (MTG) · Laboratory Medicine & Pathology
P020027 · Decided Jan 24, 2003 · 203 days after receipt
Device type: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions (MTG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Prostate Specific Antigen (Addition of ICD-9-CM 600.00, Hypertrophy (benign) of Prostate Without Urinary Obstruction, as a covered indication)Coding analysisReview closedCAG-00326NUpdated Sep 15, 2026
- Prostate Specific AntigenNational determinationOn the books190.31Updated Oct 1, 2026
- Prostate Specific Antigen (Inclusion of ICD-9-CM Code 600.01 for BPH with Urine Obstruction)Coding analysisReview closedCAG-00232NUpdated Sep 15, 2026
- Autologous Cellular Immunotherapy Treatment of Metastatic Prostate CancerNational analysisReview closedCAG-00422NUpdated Nov 19, 2026
- Abarelix for the Treatment of Prostate CancerNational analysisReview closedCAG-00238NUpdated Sep 15, 2026
- PSA (Addition of ICD-9-CM 600.21, Benign localized hyperplasia of prostate with urinary obstruction as a covered indication)Coding analysisReview closedCAG-00332NUpdated Sep 15, 2026
- Cryosurgical Salvage Therapy for Recurrent Prostate CancerNational analysisReview closedCAG-00064NUpdated Sep 14, 2026
- Cryosurgery Ablation for Prostate CancerNational analysisReview closedCAG-00031NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Dimension FPSA Flex", any status and sponsor, newest update first.
No registered device study names "Dimension FPSA Flex".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dimension FPSA Flex", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MTG
108 reports: 107 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Dimension FPSA Flex"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MTG.
- Elecsys free PSA, free PSA CalSetRoche Diagnostics Corp. · PMA 2023
- Access Hybritech free PSABeckman Coulter, Inc. · PMA 2025
- ARCHITECT Free PSAAbbott Laboratories · PMA 2020
- Dimension Vista Fpsa AssaySiemens Healthcare Diagnostics · PMA 2016
- Axsym Free PsaAbbott Laboratories · PMA 2011
- Immulite/Immulite 1000 & Immulite 2000 Free PsaSiemens Medical Solutions Diagnostics Limited · PMA 2010
- Atellica IM free PSA II (fPSAII)Siemens Healthcare Diagnostics, Inc. · PMA 2026
- IMMULITE 2000 Free PSASiemens Medical Solutions Diagnostics Limited · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.